Pharmafile Logo

Peter Impey

Ronald Berenson to lead Aequus BioPharma

Joins the Cell Therapeutics subsidiary as president and CEO

- PMLiVE

ASH meeting hears of progress with myelofibrosis drugs

New studies suggest momentum is for use of Janus kinase (JAK) inhibitors

- PMLiVE

MHRA streamlines POM-OTC reclassification rules

Aims to speed the process of switching drug status from prescription-only to over-the-counter

- PMLiVE

Eliquis meets targets as long-term VTE therapy

Pfizer and BMS report positive phase III data for the Factor Xa inhibitor

- PMLiVE

Merck KGaA picks Constantin Fest to lead investor relations

He succeeds Joshua Young who will leave the company and move to the US

- PMLiVE

INC Research appoints Robert Ryan

Joins CRO's new Strategic Advisory Services unit

- PMLiVE

Tough times for pharma in Portugal

Industry body warns of paucity of essential medicines and damage to industry reputation

- PMLiVE

EMA: move to greater clinical trial transparency ‘irreversible’

New Europe data rules could be ready by 2014

- PMLiVE

Sanofi picks corporate voice for new blogging venture

Pharma company's US arm goes beyond discussing diabetes

- PMLiVE

AstraZeneca antitrust fine upheld by European Court of Justice

Lessons for pharma as landmark ruling stands

- PMLiVE

Pfizer set for negative NICE decision on Inlyta

Institute's draft guidance doesn't recommend drug for advanced kidney cancer

- PMLiVE

Basilea’s Hans Christian Rohde takes up commercial role at uniQure

Will serve as gene therapy specialist's chief commercial officer

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links